Although the independency of Hh molecule expression on patient survival has been previously shown in bladder and prostate cancers [32, 33], we are the first to reveal that of GLI1 in lung adenocarcinoma, which is indicative of the involvement of Hh signaling in a subset of NSCLC. Here, GLI1 is linked to non-small cell lung carcinoma.